Page last updated: 2024-10-30

leflunomide and Anaplastic Astrocytoma

leflunomide has been researched along with Anaplastic Astrocytoma in 2 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vlassenko, AG1
Thiessen, B1
Beattie, BJ1
Malkin, MG1
Blasberg, RG1
Miljkovic, D1
Samardzic, T1
Mostarica Stojkovic, M1
Stosic-Grujicic, S1
Popadic, D1
Trajkovic, V1

Other Studies

2 other studies available for leflunomide and Anaplastic Astrocytoma

ArticleYear
Evaluation of early response to SU101 target-based therapy in patients with recurrent supratentorial malignant gliomas using FDG PET and Gd-DTPA MRI.
    Journal of neuro-oncology, 2000, Volume: 46, Issue:3

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Biologica

2000
Leflunomide inhibits activation of inducible nitric oxide synthase in rat astrocytes.
    Brain research, 2001, Jan-19, Volume: 889, Issue:1-2

    Topics: Animals; Astrocytes; Astrocytoma; Cell Line; Enzyme Activation; Immunosuppressive Agents; Indicators

2001